MedTek21 and AccessDX Laboratory have announced the immediate availability of a Covid-19 testing and compliance solution within New York State impacted by Executive Order No. 202.30.

The new solution for nursing homes and adult care facilities entities will enable bi-weekly infection testing and compliance tracking for all personnel, including employees, contract staff, medical staff, operators and administrators.

This is in addition to the existing Covid-19 infection and laboratory antibody testing services for residents provided by the companies.

Enacted on 10 May, New York State Executive Order No. 202.30 requires that the operators and administrators of all nursing homes and adult care facilities must make arrangements for all personnel to be tested for Covid-19 twice a week.

Fines and penalties have been established for non-compliance with the executive order, ensuring adherence is an immediate priority for facilities across New York State.

MedTek21 and AccessDX said that their rapid-response teams will ensure facility operators have prompt and continuous access to test kits, results and reporting.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

The full test status and chain-of-custody reporting are provided by the MedTek21 software, and the sample results will be available within 24-48 hours of receipt.

AccessDX Laboratory is operating under the emergency use authorisation (EUA) as filed with the US Food and Drug Administration (FDA). It is CLIA-certified, CAP-accredited and certified in New York State.

MedTek21 and AccessDX launched their Covid-19 testing and support operations in March. They currently support testing initiatives at more than 600 clinical and employer groups in the country.